期刊文献+

Comparison of Milan and UCSF criteria for liver transplantation to treat hepatocellular carcinoma 被引量:2

Comparison of Milan and UCSF criteria for liver transplantation to treat hepatocellular carcinoma
下载PDF
导出
摘要 AIM:To assess the validity of the Milan and University of California San Francisco(UCSF) criteria and examine the long-term outcome of orthotopic liver transplantation(OLT) in patients with hepatocellular carcinoma(HCC) in a single-center study.METHODS:This study is a retrospective review of prospectively collected data.Between 1998 and 2009,56 of 356 OLTs were performed in patients with HCC.Based on pathological examination of liver explants,patients were retrospectively categorized into 3 groups:Milan +(n = 34),Milan-/UCSF +(n = 7) and UCSF-(n = 14).RESULTS:Median follow-up period was 39.5(1-124) mo.The 5-year overall survival rates in the Milan +,Milan-/UCSF + and UCSF-groups were 87.7%,53.6% and 33.3%,respectively(P < 0.000).Within these groups,tumor recurrence was determined in 5.8%,14.3% and 40% of patients,respectively(P < 0.011).Additionally,the presence of microvascular invasion within the explanted liver had a negative effect on the 5-year disease free survival(74.7% vs 46.7%,P < 0.044).CONCLUSION:The Milan criteria are reliable in the selection of suitable candidates for OLT for the treatment of HCC.For cases of OLT involving living donors,the UCSF criteria may be applied. AIM:To assess the validity of the Milan and University of California San Francisco(UCSF) criteria and examine the long-term outcome of orthotopic liver transplantation(OLT) in patients with hepatocellular carcinoma(HCC) in a single-center study.METHODS:This study is a retrospective review of prospectively collected data.Between 1998 and 2009,56 of 356 OLTs were performed in patients with HCC.Based on pathological examination of liver explants,patients were retrospectively categorized into 3 groups:Milan +(n = 34),Milan-/UCSF +(n = 7) and UCSF-(n = 14).RESULTS:Median follow-up period was 39.5(1-124) mo.The 5-year overall survival rates in the Milan +,Milan-/UCSF + and UCSF-groups were 87.7%,53.6% and 33.3%,respectively(P 0.000).Within these groups,tumor recurrence was determined in 5.8%,14.3% and 40% of patients,respectively(P 0.011).Additionally,the presence of microvascular invasion within the explanted liver had a negative effect on the 5-year disease free survival(74.7% vs 46.7%,P 0.044).CONCLUSION:The Milan criteria are reliable in the selection of suitable candidates for OLT for the treatment of HCC.For cases of OLT involving living donors,the UCSF criteria may be applied.
出处 《World Journal of Gastroenterology》 SCIE CAS CSCD 2011年第37期4206-4212,共7页 世界胃肠病学杂志(英文版)
  • 相关文献

参考文献1

二级参考文献81

  • 1Parkin DM,Bray F,Ferlay J,Pisani P.Estimating the world cancer burden:Globocan 2000.Int J Cancer 2001; 94:153-156.
  • 2Befeler AS,Di Bisceglie AM.Hepatocellular carcinoma:diagnosis and treatment.Gastroenterology 2002; 122:1609-1619.
  • 3Liu JH,Chen PW,Asch SM,Busuttil RW,Ko CY.Surgery for hepatocellular carcinoma:does it improve survival? Ann Surg Oncol 2004; 11:298-303.
  • 4Fong TL,Kanel GC,Conrad A,Valinluck B,Charboneau F,Adkins RH.Clinical significance of concomitant hepatitis C infection in patients with alcoholic liver disease.Hepatology 1994; 19:554-557.
  • 5Ming L,Thorgeirsson SS,Gail MH,Lu P,Harris CC,Wang N,Shao Y,Wu Z,Liu G,Wang X,Sun Z.Dominant role of hepatitis B virus and cofactor role of aflatoxin in hepatocarcinogenesis in Qidong,China.Hepatology 2002; 36:1214-1220.
  • 6Hassan MM,Hwang LY,Hatten CJ,Swaim M,Li D,Abbruzzese JL,Beasley P,Patt YZ.Risk factors for hepatocellular carcinoma:synergism of alcohol with viral hepatitis and diabetes mellitus.Hepatology 2002; 36:1206-1213.
  • 7Ohata K,Hamasaki K,Toriyama K,Matsumoto K,Saeki A,Yanagi K,Abiru S,Nakagawa Y,Shigeno M,Miyazoe S,Ichikawa T,Ishikawa H,Nakao K,Eguchi K.Hepatic steatosis is a risk factor for hepatocellular carcinoma in patients with chronic hepatitis C virus infection.Cancer 2003; 97:3036-3043.
  • 8El-Serag HB,Richardson PA,Everhart JE.The role of diabetes in hepatocellular carcinoma:a case-control study among United States Veterans.Am J Gastroenterol 2001; 96:2462-2467.
  • 9Davila JA,Morgan RO,Shaib Y,McGlynn KA,El-Serag HB.Diabetes increases the risk of hepatocellular carcinoma in the United States:a population based case control study.Gut 2005; 54:533-539.
  • 10Chokshi MM,Marrero JA.Hepatocellular carcinoma.Curr Opin Gastroenterol 2001; 17:276-280.

共引文献49

同被引文献25

引证文献2

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部